查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1870996

頭孢噻呋市場按動物種類、適應症、給藥途徑、劑型和最終用戶分類－2025-2032年全球預測

Ceftiofur Market by Animal Type, Indication, Route, Formulation, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，頭孢噻呋市場規模將成長至 8.7,282 億美元，複合年成長率為 8.90%。

關鍵市場統計數據
基準年 2024 4.4125億美元
預計年份：2025年 4.7985億美元
預測年份 2032 8.7282億美元
複合年成長率 (%) 8.90%

全面介紹頭孢噻呋在現代獸醫學中的治療作用、監管現狀、合理使用預期以及相關人員的優先事項

頭孢噻呋因其頻譜抗菌活性和在多種畜禽物種中確立的臨床效用，在獸醫學領域仍保持著核心抗菌藥物的地位。其在治療通訊協定中的作用不斷受到臨床證據、獸醫實踐標準以及全球對抗菌藥物管理日益成長的關注的影響。對於臨床醫生、農場管理者和供應鏈負責人需要在權衡治療效益與監管和公共衛生要求之間相關人員。

分析正在重塑獸醫領域頭孢噻呋應用、供應鏈、抗菌藥物管理和產品創新的變革性轉變

由於監管政策的變化、供應鏈重組和技術創新，頭孢噻呋的研發、分銷和處方格局正在發生顯著變革時期。日益嚴格的監管審查和日益嚴格的合理用藥計劃正在重塑產品標籤、適應症和配藥方式。這些因素迫使生產者和經銷商重新思考其生命週期策略，增加對處方醫師的針對性教育投入，並探索既能支持合理用藥又能維持療效的製劑創新。

對 2025 年美國關稅對 Safeway 的供應、採購和貿易趨勢的累積經濟和營運影響進行詳細評估。

美國2025年實施的關稅對頭孢噻呋供應鏈產生了多方面的影響，改變了採購經濟效益和下游營運規劃。關稅調整增加了受影響貿易夥伴提供的某些活性藥物原料藥和藥品的到岸成本，迫使採購團隊重新評估其供應商組合，並加快對替代供應來源的資格認證。因應措施包括短期戰術性調整，例如改變運輸路線和調整安全存量基準，以及長期策略決策，例如關鍵採購的在地化或區域化。

對動物種類、臨床適應症、給藥途徑、製劑選擇和最終用戶特徵如何影響使用模式進行詳細的細分分析

細分市場分析揭示了不同動物種類、臨床適應症、給藥途徑、製劑偏好和終端使用者環境如何影響治療用途和商業性重點。依動物種類分類，市場可細分為牛、家禽和豬，其中牛又可進一步細分為牛和牛。每個細分市場都展現出獨特的疾病特徵、給藥方案和經濟接受度，這些因素都會影響產品選擇和給藥策略。依疾病適應症分類，市場涵蓋胃腸道、呼吸道和性行為感染感染疾病等多種感染疾病，其中呼吸道疾病類別又可進一步細分為牛呼吸道疾病、家禽呼吸道疾病和豬呼吸道疾病，反映了不同物種的病原體流行情況和治療方法。

區域資訊整合了關鍵區域的促進因素、法規環境、供應鏈現狀和臨床需求趨勢

區域趨勢對頭孢噻呋的監管、供應和使用起著至關重要的作用，美洲、歐洲、中東和非洲以及亞太地區呈現出截然不同的模式。在美洲，監管協調工作與顯著的國家差異並存，影響許可核准時間和處方標準。該地區龐大的商業畜牧業注重生產力和疾病預防，因此對兼顧療效、符合監管要求以及滿足消費者合理用藥期望的治療方案有著強烈的需求。

從公司層級深入洞察頭孢噻呋供應的競爭定位、研發重點、夥伴關係關係、商業化策略和業務永續營運。

在頭孢噻呋領域，各公司之間的競爭主要體現在研發能力、法規事務、生產規模和分銷管道等。投資於製劑創新（例如高濃度液體製劑和簡化農場給藥的即用型製劑）的公司，能夠在滿足醫療專業人員對更便捷用藥和更精確劑量的需求的同時，實現差異化競爭優勢。同樣重要的是，投資於藥物警戒、品質系統和法規合作，以成功應對不斷變化的標籤要求和合理用藥法規。

為行業領導者提供切實可行的建議，以透過夥伴關係加強供應鏈韌性、促進負責任的使用並提高商業性敏捷性

產業領導者應採取切實可行的行動方案，以平衡療效、監管責任和供應韌性。首先，企業應投資於關鍵原料和成品的多源合格和雙重籌資策略，以降低貿易政策變化和物流瓶頸帶來的風險。這種營運緊急時應對計畫應與基於情境的庫存管理政策和合約條款相結合，以便在供應中斷時能夠快速重新分配物資。

透明的調查方法，說明了主要和次要資料的收集、檢驗通訊協定、專家諮詢和分析保障措施。

本分析基於混合調查方法，結合了結構化的初步研究、全面的二次文獻綜述以及嚴格的檢驗通訊協定。初步數據包括與臨床獸醫、供應鏈和監管專家以及商業領袖的專家諮詢，這些專家提供了關於臨床實踐、採購行為和監管合規性的經驗觀點。二次文獻包括已發布的監管文件、臨床指南和同行評審文獻，這些資料用於建立臨床背景並對初步研究結果進行三角驗證。

一份綜合性報告，重點闡述了管理優先事項、供應連續性需求和實際意義，旨在指導獸醫決策者。

本文提出的各項研究結果共同指向一些核心要務，這些要務應指南所有與頭孢噻呋及相關動物醫藥相關的相關人員。作為永續利用的基石，管理和監管誠信不容妥協。努力提高診斷準確性和加強處方醫師教育，將有助於改善臨床療效並維持公司聲譽。強調多元化、合約彈性和品質保證的供應鏈策略對於降低貿易政策波動和物流不穩定性的風險至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大長效注射頭孢噻呋在牛呼吸道疾病治療的應用
  • 抗菌藥物使用監管的日益嚴格正在推動頭孢噻呋殘留監測技術的創新。
  • 擴大頭孢噻呋在豬隻健康通訊協定中的使用（由於人們越來越擔心豬繁殖與呼吸綜合症病毒的合併感染）
  • 一種新型頭孢噻呋遞送系統可提高標靶釋放效率並降低給藥頻率。
  • 透過整合快速農場診斷技術，最佳化頭孢噻呋治療策略並最大限度地降低抗藥性風險

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依動物種類分類的頭孢噻呋市場

  • 牛
    • 牛
    • 乳牛
  • 家禽
  • 豬

9. 依適應症分類的頭孢噻呋市場

  • 胃腸道感染疾病
  • 呼吸道感染疾病
    • 牛呼吸道疾病
    • 家禽呼吸道疾病
    • 豬的呼吸系統疾病
  • 全身性行為感染

第10章 頭孢噻呋市場通路

  • 注射
    • 肌肉內注射
    • 靜脈注射
    • 皮下注射
  • 口服

第11章 以劑型分類的頭孢噻呋市場

  • 液體
    • 濃縮液
    • 即用型
  • 粉末
  • 預混合料

第12章 頭孢噻呋市場（以最終用戶分類）

  • 農場
    • 大型農場
    • 小農場
  • 零售藥房
  • 獸醫診所

13. 各地區頭孢噻呋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 頭孢噻呋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國頭孢噻呋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Ceva Sante Animale SA
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Virbac SA
    • Vetoquinol SA
    • Huvepharma NV
    • Norbrook Laboratories Limited
    • Phibro Animal Health Corporation
Product Code: MRR-1A1A064C0547

The Ceftiofur Market is projected to grow by USD 872.82 million at a CAGR of 8.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 441.25 million
Estimated Year [2025] USD 479.85 million
Forecast Year [2032] USD 872.82 million
CAGR (%) 8.90%

Comprehensive introduction to ceftiofur's therapeutic role in modern veterinary care, regulatory landscape, stewardship expectations, and stakeholder priorities

Ceftiofur remains a cornerstone antimicrobial in veterinary medicine, valued for its broad-spectrum activity and established clinical utility across multiple livestock species. Its role within therapeutic protocols continues to be shaped by evolving clinical evidence, veterinary practice standards, and an intensifying global focus on antimicrobial stewardship. As stakeholders weigh therapeutic benefits against regulatory and public health obligations, a clear understanding of ceftiofur's clinical indications, routes of administration, and formulation options becomes essential for clinicians, farm managers, and supply chain planners alike.

Regulatory frameworks and stewardship expectations vary by jurisdiction, influencing prescribing behavior and product availability. Concurrently, advances in diagnostic capacity and disease surveillance are accelerating the shift from empiric to targeted therapy in many settings, which affects how ceftiofur is used in practice. Economic pressures on producers and distributors, coupled with heightened scrutiny from consumers and regulators, underscore the need for strategic clarity around procurement, inventory management, and responsible use policies. This introduction sets the stage for a focused analysis that integrates clinical, regulatory, and commercial perspectives to support informed decision-making.

Analysis of transformative shifts reshaping ceftiofur application, supply chains, antimicrobial stewardship, and product innovation in veterinary sectors

The landscape in which ceftiofur is developed, distributed, and prescribed is undergoing substantive change driven by regulatory shifts, supply chain reconfiguration, and technological innovation. Heightened regulatory scrutiny and an increasingly stringent stewardship agenda are reshaping product labeling, permissible indications, and dispensing practices. These forces are prompting manufacturers and distributors to reexamine lifecycle strategies, invest in targeted education for prescribers, and explore formulation innovations that support judicious use while maintaining therapeutic efficacy.

At the same time, supply chain pressures-from raw material sourcing to finished-goods logistics-are driving organizations to diversify suppliers, strengthen inventory controls, and adopt more transparent procurement practices. Advancements in diagnostics, including rapid detection tools and improved laboratory networks, are enabling earlier and more accurate disease identification, which in turn informs more precise antimicrobial selection. Collectively, these shifts are encouraging a transition from volume-based distribution models toward value-based approaches that prioritize outcomes, traceability, and long-term sustainability. Stakeholders that anticipate and adapt to these transformative trends will be better positioned to align clinical needs, regulatory expectations, and commercial resilience.

Detailed evaluation of the cumulative economic and operational impact of United States tariffs enacted in 2025 on ceftiofur supply, sourcing, and trade dynamics

The United States tariffs introduced in 2025 have had a multi-dimensional effect on the ceftiofur supply continuum, altering sourcing economics and downstream operational planning. Tariff adjustments increased landed costs for certain active pharmaceutical ingredients and formulated products originating from affected trade partners, prompting procurement teams to reassess supplier portfolios and to accelerate qualification of alternative sources. This response encompassed both near-term tactical shifts-such as re-routing shipments and adjusting safety stock levels-and longer-term strategic decisions to localize or regionalize critical sourcing.

Pricing pressures were complemented by logistical constraints as some suppliers prioritized markets with fewer trade frictions, thereby creating short windows of constrained availability for distributors and end users. Regulatory compliance and quality-assurance requirements limited the universe of acceptable alternative sources, which added complexity to supplier transitions. In response, many organizations enhanced contract flexibility and invested in scenario planning to maintain supply continuity. The tariff-induced environment also catalyzed conversations about vertical integration and contractual hedging to reduce exposure to future trade policy volatility. As a result, stakeholders are increasingly embedding geopolitical risk assessments into procurement planning and clinical continuity strategies.

In-depth segmentation insights on how animal type, clinical indications, administration routes, formulation choices and end-user profiles shape use patterns

Segmentation analysis illuminates how therapeutic use and commercial priorities diverge across animal types, clinical indications, routes of administration, formulation preferences, and end-user settings. Within animal type, the market is differentiated by Cattle, Poultry, and Swine, with Cattle further subdivided into Beef Cattle and Dairy Cattle; each segment exhibits distinct disease profiles, dosing regimens, and economic tolerances that influence product selection and administration strategies. Disease indication segmentation shows varied use across Gastrointestinal Infections, Respiratory Infections, and Systemic Infections, and the respiratory category is further distinguished by Bovine Respiratory Disease, Poultry Respiratory Disease, and Swine Respiratory Disease, reflecting species-specific pathogen prevalence and management practices.

Route-based segmentation highlights the predominance of Injectable and Oral administration, with the Injectable route further differentiated into Intramuscular, Intravenous, and Subcutaneous approaches that carry implications for dosing accuracy, withdrawal periods, and on-farm administration logistics. Formulation analysis distinguishes Liquid, Powder, and Premix offerings, where Liquid products are further categorized into Concentrate and Ready To Use variants that affect handling, storage, and dosing convenience. End-user segmentation underscores divergent procurement behaviors and usage patterns across Farm, Retail Pharmacies, and Veterinary Clinics, with Farm users split into Large Farms and Small Farms; these distinctions drive preferences for pack sizes, formulation types, and service-level expectations. Together, these segmentation lenses enable a granular understanding of demand drivers and operational constraints, and inform targeted strategies for product development, distribution, and stewardship initiatives.

Regional intelligence that synthesizes drivers, regulatory environments, supply chain realities, and clinical demand trends across major global regions

Regional dynamics play a decisive role in how ceftiofur is regulated, accessed, and deployed, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory harmonization efforts coexist with significant heterogeneity at the national level, influencing licensing timelines and prescribing norms. The region's large commercial livestock sectors emphasize productivity and disease prevention, which results in strong demand for therapeutics that balance efficacy with regulatory compliance and consumer expectations for responsible use.

Europe, Middle East & Africa present a varied regulatory tapestry where stewardship imperatives and consumer-facing transparency demands are especially pronounced in many European markets, while certain EMEA territories are still building diagnostic and distribution infrastructures. Asia-Pacific demonstrates fast-evolving demand patterns driven by rapid intensification of production systems, expanding veterinary services, and increasing regulatory attention to antimicrobial resistance. Across all regions, supply chain resilience, regulatory clarity, and the availability of veterinary expertise are the primary determinants of how ceftiofur is positioned and utilized. Businesses that tailor commercial approaches to regional regulatory climates, distribution realities, and clinical priorities will find better alignment with local stakeholders and greater operational success.

Strategic company-level insights spotlighting competitive positioning, R&D focus, partnerships, commercialization tactics and operational resilience in ceftiofur supply

Competitive dynamics among companies operating in the ceftiofur space are defined by capabilities in R&D, regulatory affairs, manufacturing scale, and distribution reach. Firms that invest in formulation innovation, such as concentrated liquid formats or ready-to-use presentations that simplify on-farm administration, can secure differentiation while addressing practitioner preference for convenience and dosing accuracy. Equally important are investments in pharmacovigilance, quality systems, and regulatory engagement to navigate evolving labeling requirements and stewardship-related restrictions.

Strategic partnerships and contract manufacturing relationships have become critical levers for operational continuity, enabling flexibility in sourcing and capacity scaling. Companies with diversified supply chains and transparent traceability practices have demonstrated greater resilience to trade disruptions and regulatory shifts. Commercially, successful organizations often combine evidence-based education for veterinarians and farm personnel with targeted support services that address withdrawal management, dosing optimization, and stewardship compliance. Those that align their R&D and commercialization strategies with prevailing clinical needs and regulatory expectations are better positioned to retain trust among prescribers and end users while maintaining operational stability.

Actionable recommendations for industry leaders to strengthen supply chain resilience, promote responsible use, and enhance commercial agility through partnerships

Industry leaders should adopt a pragmatic set of actions to balance therapeutic effectiveness with regulatory responsibility and supply resilience. First, firms should invest in multi-source qualification and dual-sourcing strategies for critical inputs and finished products to reduce vulnerability to trade policy changes and logistical bottlenecks. This operational contingency planning should be paired with scenario-based inventory policies and contractual terms that permit rapid reallocation of supply when disruptions occur.

Second, strengthening stewardship requires coordinated investment in diagnostics, practitioner education, and data capture to enable targeted therapy and to demonstrate responsible use. Third, formulation and route optimization-including exploration of ready-to-use liquid presentations and administration protocols that lower the risk of dosing errors-can improve adherence and reduce inadvertent selection pressure. Fourth, commercial strategies should prioritize transparent engagement with regulators, veterinarians, and farm operators to align on labeling, withdrawal guidance, and usage monitoring. Finally, leaders should pursue partnerships that enhance distribution agility and invest in analytics that convert operational data into actionable intelligence for procurement, pharmacovigilance, and clinical outcomes tracking. Together these actions create a pragmatic roadmap for operational and clinical resilience.

Transparent research methodology describing primary and secondary data collection, validation protocols, expert consultation, and analytic safeguards

This analysis is grounded in a mixed-methods research approach that combines structured primary research with comprehensive secondary review and rigorous validation protocols. Primary inputs include expert consultations with practicing veterinarians, supply chain and regulatory specialists, and commercial leaders, all of whom provide grounded perspectives on clinical practice, procurement behavior, and regulatory compliance. Secondary inputs consist of publicly available regulatory documents, clinical guidelines, and peer-reviewed literature used to establish clinical context and to triangulate primary findings.

Data validation was achieved through cross-verification of supplier and regulatory information across multiple sources, and by reconciling practitioner-reported behaviors with documented industry trends. Analytical methods included thematic synthesis for qualitative inputs and scenario analysis for supply chain and policy-driven impacts. Limitations are acknowledged, including variability in regional data transparency and the evolving nature of regulatory guidance; where appropriate, assumptions are explicitly stated and sensitivity considerations are applied. The methodology emphasizes transparency and reproducibility to ensure that conclusions are robust and relevant for decision-makers.

Concluding synthesis highlighting stewardship priorities, supply continuity imperatives, and practical implications to guide decision-makers in veterinary therapeutics

The cumulative insights presented here converge on several core imperatives that should guide stakeholders engaged with ceftiofur and related veterinary therapeutics. Stewardship and regulatory alignment are non-negotiable foundations for sustainable use; efforts to improve diagnostic precision and to educate prescribers will yield dividends in both clinical outcomes and reputational resilience. Supply chain strategies that emphasize diversification, contractual flexibility, and quality assurance are essential to mitigate exposure to trade policy shifts and logistical volatility.

Commercial success will increasingly depend on the ability to tailor product offerings and service models to differentiated end-user needs, whether those are large integrated farms seeking scalable solutions or smaller operations that require more hands-on support. Companies that invest in responsible-use messaging, transparent traceability, and collaborative partnerships with veterinary stakeholders will be best placed to navigate evolving regulatory landscapes and to sustain clinical relevance. The synthesis underscores the importance of integrating clinical, operational, and commercial perspectives to drive pragmatic, evidence-based decisions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of long-acting ceftiofur injectable formulations for bovine respiratory disease management
  • 5.2. Growing regulatory restrictions on antimicrobial usage driving innovation in ceftiofur residue monitoring technologies
  • 5.3. Expansion of ceftiofur usage in swine health protocols amid increasing PRRS virus co-infection concerns
  • 5.4. Emergence of novel ceftiofur delivery systems improving targeted release and reducing dosing frequency
  • 5.5. Integration of rapid on-farm diagnostics to optimize ceftiofur treatment strategies and minimize resistance risk

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ceftiofur Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef Cattle
    • 8.1.2. Dairy Cattle
  • 8.2. Poultry
  • 8.3. Swine

9. Ceftiofur Market, by Indication

  • 9.1. Gastrointestinal Infections
  • 9.2. Respiratory Infections
    • 9.2.1. Bovine Respiratory Disease
    • 9.2.2. Poultry Respiratory Disease
    • 9.2.3. Swine Respiratory Disease
  • 9.3. Systemic Infections

10. Ceftiofur Market, by Route

  • 10.1. Injectable
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral

11. Ceftiofur Market, by Formulation

  • 11.1. Liquid
    • 11.1.1. Concentrate
    • 11.1.2. Ready To Use
  • 11.2. Powder
  • 11.3. Premix

12. Ceftiofur Market, by End User

  • 12.1. Farm
    • 12.1.1. Large Farms
    • 12.1.2. Small Farms
  • 12.2. Retail Pharmacies
  • 12.3. Veterinary Clinics

13. Ceftiofur Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ceftiofur Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ceftiofur Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Ceva Sante Animale SA
    • 16.3.3. Merck & Co., Inc.
    • 16.3.4. Elanco Animal Health Incorporated
    • 16.3.5. Boehringer Ingelheim International GmbH
    • 16.3.6. Virbac SA
    • 16.3.7. Vetoquinol SA
    • 16.3.8. Huvepharma NV
    • 16.3.9. Norbrook Laboratories Limited
    • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEFTIOFUR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CEFTIOFUR MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CEFTIOFUR MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEFTIOFUR MARKET SIZE, BY ROUTE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CEFTIOFUR MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEFTIOFUR MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CEFTIOFUR MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEFTIOFUR MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CEFTIOFUR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CEFTIOFUR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CEFTIOFUR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CEFTIOFUR MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CEFTIOFUR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CEFTIOFUR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CEFTIOFUR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CEFTIOFUR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CEFTIOFUR MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CEFTIOFUR MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CEFTIOFUR MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CEFTIOFUR MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CEFTIOFUR MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CEFTIOFUR MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CEFTIOFUR MARKET SIZE, BY BOVINE RESPIRATORY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CEFTIOFUR MARKET SIZE, BY POULTRY RESPIRATORY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CEFTIOFUR MARKET SIZE, BY SWINE RESPIRATORY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CEFTIOFUR MARKET SIZE, BY SYSTEMIC INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CEFTIOFUR MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CEFTIOFUR MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CEFTIOFUR MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CEFTIOFUR MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CEFTIOFUR MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CEFTIOFUR MARKET SIZE, BY CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CEFTIOFUR MARKET SIZE, BY READY TO USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CEFTIOFUR MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CEFTIOFUR MARKET SIZE, BY PREMIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CEFTIOFUR MARKET SIZE, BY FARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CEFTIOFUR MARKET SIZE, BY LARGE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CEFTIOFUR MARKET SIZE, BY SMALL FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CEFTIOFUR MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CEFTIOFUR MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CEFTIOFUR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CEFTIOFUR MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS CEFTIOFUR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS CEFTIOFUR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 345. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 346. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 347. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 348. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 349. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 350. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2025-2032 (USD MILLION)
  • TABLE 351. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 352. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 353. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
  • TABLE 354. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY LIQUID, 2025-2032 (USD MILLION)
  • TABLE 355. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 356. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 357. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY FARM, 2018-2024 (USD MILLION)
  • TABLE 358. ASIA-PACIFIC CEFTIOFUR MARKET SIZE, BY FARM, 2025-2032 (USD MILLION)
  • TABLE 359. GLOBAL CEFTIOFUR MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 360. GLOBAL CEFTIOFUR MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 361. ASEAN CEFTIOFUR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 362. ASEAN CEFTIOFUR MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 363. ASEAN CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. ASEAN CEFTIOFUR MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. ASEAN CEFTIOFUR MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 366. ASEAN CEFTIOFUR MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 367. ASEAN CEFTIOFUR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 368. ASEAN CEFTIOFUR MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 369. ASEAN CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 370. ASEAN CEFTIOFUR MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 371. ASEAN CEFTIOFUR MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 372. ASEAN CEFTIOFUR MARKET SIZE, BY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 373. ASEAN CEFTIOFUR MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 374. ASEAN CEFTIOFUR MARKET SIZE, B